The pharmaceutical industry is particularly vulnerable with often continuous and energy-intensive manufacturing processes, and even the smallest power interruption can halt production. Reliable power delivery during high impact events, like COVID-19, is crucial to providing the regular quality of service during these destructive occurrences.

This paper explores how commercial, industrial, and institutional organizations can address electric resiliency challenges through onsite power leveraging traditional fuels to the newest technologies.